Two populations of TSPO binding sites in oral cancer SCC-15 cells.

Exp Cell Res

Department of Neuroscience, Faculty of Medicine, Rappaport Family Institute for Research in the Medical Sciences, Technion - Israel Institute of Technology, Haifa, Israel. Electronic address:

Published: January 2017

AI Article Synopsis

  • Oral cancer continues to have high mortality and morbidity rates, with cigarette smoke identified as a primary cause.
  • Researchers focused on the binding sites of the translocator protein 18kDa (TSPO) in human oral cancer cells (SCC-15) and how cigarette smoke affects these sites.
  • The study found two sub-populations of TSPO binding sites with different affinities and a significant reduction in the high-affinity binding after exposure to cigarette smoke, suggesting that this interaction may help explain how oral cancer develops.

Article Abstract

Oral cancer mortality and morbidity rates remain high. The main inducer of oral cancer is cigarette smoke (CS). Translocator protein 18kDa (TSPO) was shown to play a role in carcinogenesis. We characterized TSPO binding sites in human oral cancer cell line SCC-15 and examined effect of CS on TSPO binding. We exposed SCC-15 human squamous cells to cigarette smoke. [H]PK 11195 binding results were assessed in cells confluent for one day. To characterize the number of population sites, a custom written Matlab program compared Pearson linear correlation coefficients between all points in the Scatchard plot. Using [H]PK 11195 as a radio ligand, we found that TSPO binding sites are not uniform, but separated into two sub-populations, one with high affinity (respective Kd and Bmax values of 1.40±0.08nM and 1586±48 fmol/mg protein), another with lower affinity (respective Kd and Bmax values of 61±5nM and 26260±1050 fmol/mg protein). We demonstrate rapid decrease in TSPO binding to the high affinity site induced by exposure to CS; specifically, significant 36% decrease in binding after 30min CS exposure (p<0.05), and 69% decrease after 2h CS exposure (p<0.05). Association between TSPO and CS exposure may contribute to understanding the underlying mechanism of oral carcinogenesis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2016.12.005DOI Listing

Publication Analysis

Top Keywords

tspo binding
20
oral cancer
16
binding sites
12
cigarette smoke
8
[h]pk 11195
8
high affinity
8
affinity respective
8
respective bmax
8
bmax values
8
fmol/mg protein
8

Similar Publications

[F]SF51 is a novel radioligand for imaging translocator protein 18 kDa (TSPO) that previously displayed excellent imaging properties in nonhuman primates. This study assessed its performance in human brain and its dosimetry. Seven healthy participants underwent brain PET imaging to measure TSPO binding using a two-tissue compartment model (2TCM) to calculate total distribution volume ().

View Article and Find Full Text PDF
Article Synopsis
  • The translocator protein 18 kDa (TSPO) plays a key role in cholesterol movement for steroid production and serves as a marker for neuroinflammation, linking it to neurodegenerative and neuropsychiatric disorders.
  • The review focuses on the structural diversity and modifications of TSPO ligands, showcasing advancements in their design for better binding effectiveness and specificity.
  • It also highlights the progress of some TSPO ligands that are currently in clinical trials, aiming to inform researchers about structure-activity relationships for potential new therapies targeting TSPO in neuroinflammatory diseases.
View Article and Find Full Text PDF

Septic cardiomyopathy (SCM) is a critical complication of sepsis, primarily attributed to mitochondrial dysfunction and impaired autophagic flux. This study explores the role of translocator protein (TSPO) in SCM pathogenesis and assesses its potential as a therapeutic target. We identified increased TSPO expression in plasma samples from sepsis patients, with further validation in septic rats and LPS-stimulated H9C2 cardiomyocytes.

View Article and Find Full Text PDF

The microglial translocator protein (TSPO) in Alzheimer's disease reflects a phagocytic phenotype.

Acta Neuropathol

November 2024

Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, SO16 6YD, UK.

Article Synopsis
  • TSPO (translocator protein) is a mitochondrial protein found in microglia and is used as a neuroinflammation marker in PET scans for Alzheimer's disease (AD).
  • This study aims to better understand the microglial phenotype linked to TSPO expression by analyzing human brain samples from different stages of AD.
  • The findings indicate that TSPO is primarily associated with phagocytic microglia (specifically CD68), suggesting a role in ongoing neurodegeneration in Alzheimer's disease.
View Article and Find Full Text PDF

miRNA-148a-3p targets to regulate the lipid metabolism gene SOCS3 to reduce myocardial ischemia/reperfusion injury.

Minerva Cardiol Angiol

November 2024

Guangxi Key Laboratory of Basic Medical Research Support for Immune-related Diseases, Baise, Guangxi, China -

Background: Acute myocardial infarction (AMI) is a major cause of death in cardiovascular patients. SOCS3's protective role in cardiac I/R-I is being explored, and miRNAs, particularly miRNA-148a-3p, are suspected to target SOCS3. To elucidate the role of miRNA-148a-3p targeting lipid metabolism gene SOCS3 in cardiac ischemia-reperfusion injury (I/R-I) in rats.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!